Cygnus GlucoWatch Launch Contingent On AutoSensor Facility Clearance

Full-scale U.S. launch of Cygnus' GlucoWatch Biographer non-invasive glucose monitoring system will await FDA approval of a primary manufacturing site for the AutoSensor component, the firm says.

More from Archive

More from Medtech Insight